Comment: Vancomycin and Tobramycin Continuous Hemofiltration Clearance Methodologies

Armstrong DK Hidalgo HA Eldadah M . Vancomycin and tobramycin clearance in an infant during continuous hemofiltration. Ann Pharmacother 1993; 27: 224–7.

Henderson LW . Ultrafiltration biophysics. In: Maher JF , ed. Replacement of renal function by dialysis. 3rd ed. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1989: 312.

Golper TA Wedel SK Kaplan AA Saad AM Donta ST Paganini EP . Drug removal during continuous arteriovenous hemofiltration: Theory and clinical observations. Int J Artif Organs 1985; 8: 307–12.

Kronfol NO Lau AH Libertin Colon-Rivera CL . Effect of CAVH membrane types on drug sieving coefficients and clearances. Trans Am Soc Artif Intern Organs 1986; 32: 85–7.

Golper TA Pulliam J Bennett WM . Removal of therapeutic drugs by continuous arterial hemofiltration. Arch Intern Med 1985; 145: 1651–2.

MacIas WL Mueller BA Scarim SK . Vancomycin pharmacokinetics in acute renal failure: Preservation of nonrenal clearance. Clin Pharmacol Ther 1991; 50: 688–94.

Mueller BA Scarim SK MacIas WL . Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration. Am J Kidney Dis 1993; 21: 172–9.